Strontium Citrate.

Strontium and calcium are chemically similar divalent cations and compete for the same intestinal transport routes, so taking them in one serving lowers how much strontium is absorbed. The usual practice is to separate the two doses by several hours rather than combine them.

Vitamin D raises expression of the intestinal calcium transport proteins, and strontium crosses the gut wall on that same route. Adequate vitamin D status therefore supports the mineral handling that carries strontium to bone.

Strontium deposits into the hydroxyapatite crystal of bone, while vitamin K2 carboxylates osteocalcin so the protein matrix can bind mineral. The two act on different halves of the same bone building step, mineral and matrix.

Vitamin C is required by the hydroxylases that build and crosslink bone collagen, so it supports the matrix that bone mineral is built into.

Strontium and calcium move through the same intestinal calcium transport machinery and each cuts the other's uptake, so the standard instruction is to take them at different times.

A carbonate calcium dose is large by mass and competes with strontium for the same absorption route, which is why the two are not taken in the same serving.

MK-7 carboxylates osteocalcin so it can bind mineral into bone and keeps matrix Gla protein active elsewhere, the step that directs supplemental bone mineral where it belongs.

Silicon supports the collagen scaffold bone mineral is deposited onto, working on the organic side of bone while strontium works on the mineral side.

Boron changes calcium and magnesium retention and supports the vitamin D and steroid steps behind normal bone turnover, which is why bone formulas carry it.

Manganese is the metal cofactor for the enzymes that assemble bone and cartilage proteoglycan, part of matrix building that the mineral phase does not cover.

Collagen peptides supply glycine and proline plus peptide signals for the type I collagen framework of bone, the scaffold that carries the mineral phase.

Soluble bulk fibre binds divalent minerals in the lumen and carries part of the dose past the absorption window, so strontium taken with psyllium is less available.

Strontium and magnesium are both divalent cations absorbed largely through the same paracellular and carrier-mediated routes in the small intestine, so a large dose of one taken with the other reduces how much of each is picked up. Magnesium also has its own established role in normal bone structure, which is why the two show up in the same formulas. The practical handling is to separate the doses rather than drop either. The competition is at absorption, not in the bone itself.

High doses of one divalent mineral routinely reduce uptake of another sharing the same transport capacity, and strontium behaves like a bulky calcium analogue in that system. Zinc taken in the same dose window is the losing side when strontium is given at the doses used in supplements. Spacing them by several hours resolves it. No human absorption study for this specific pair appears in the candidate set.

Non-heme iron uptake is reduced by co-ingested divalent minerals at supplement doses, a well-described effect for calcium that extends to its chemical analogue strontium. Anyone taking both should put a few hours between them, and iron is usually the one moved to an empty stomach. This is an absorption interaction, not a claim about iron status. It matters most when iron intake is already marginal.

Strontium, like calcium, forms sparingly soluble phosphate salts, so a phosphate-heavy meal or a phosphorus supplement taken at the same time reduces how much strontium stays in solution to be absorbed. The chemistry is the same one that governs calcium phosphate precipitation. Taking strontium away from meals is the standard formulation answer. Phosphorus itself is not depleted by the pairing.

Tannins bind divalent metal cations in the gut lumen and form complexes that are not absorbed, which is the same mechanism behind tea reducing non-heme iron uptake. Strong tea, tannin-rich extracts and strontium in the same window pull in opposite directions. Separating them by a couple of hours is enough. The binding happens in the gut, not systemically.

Phytate in whole grains and legumes chelates divalent cations and holds them unabsorbed; supplemental phytase hydrolyses phytate and frees those cations. Applied to strontium the expectation follows from its behaviour as a calcium analogue rather than from a direct measurement. Read it as mechanistic. It is most relevant for people eating a high-phytate diet.

Fermentation of inulin lowers colonic pH and increases the soluble fraction of divalent minerals available for absorption further down the tract, an effect described most clearly for calcium and magnesium. Strontium is handled like calcium, so the same direction is expected. This is inference from a chemical analogue, not a measured strontium result. It is a modest effect in any case.

Galactooligosaccharides are fermented to short chain fatty acids that drop luminal pH and keep divalent cations soluble in the large bowel. The evidence base sits with calcium and magnesium; strontium is extrapolated from its analogue behaviour. The effect is real but small next to dose timing. Label it mechanistic rather than clinical.

Resistant starch reaches the colon and is fermented, lowering pH in the same way other prebiotic substrates do and keeping divalent minerals in solution. The strontium link is by analogy to calcium rather than by direct measurement. It costs nothing to combine them. Do not expect it to substitute for taking strontium away from calcium-rich meals.

Mineral salts have to dissolve before they can be absorbed and low gastric acidity reduces dissolution of the less soluble ones, which is why acid-dependent forms are advised with food. Strontium citrate is already a reasonably soluble organic salt, so the gain is smaller here than for carbonate forms. The relationship is established chemistry applied to a specific salt. It matters more in older adults with reduced gastric acid output.

Caffeine produces a small, well-described increase in urinary calcium loss, and strontium is handled by the kidney along similar lines as a calcium analogue. The direction is toward greater loss rather than reduced absorption. The size of the effect is modest and offset by adequate intake. This is an extrapolation from calcium physiology, not a measured strontium result.

Sodium and calcium share reabsorption handling in the renal tubule, so a high sodium load increases urinary calcium output, an established renal relationship. Strontium follows calcium handling closely enough that the same direction applies. Nothing here says strontium status falls; it describes the excretion side. Moderating sodium is the sensible framing rather than avoiding it.

Potassium citrate and similar alkalising salts reduce urinary calcium excretion by lowering net acid load, which is the mirror image of the sodium effect. Strontium is handled similarly to calcium in the tubule. The pairing points in a retention direction. It is a mechanistic argument drawn from calcium work, not a strontium measurement.

Phosphatidylserine binds divalent cations at the membrane level in laboratory systems, which is sometimes read as a mineral interaction in formulas. At oral supplement doses there is no established effect on strontium absorption or retention. The row exists to record that the connection is theoretical. Nothing in the candidate set measures it.